Pharmaceutical The growth of the Russian pharmaceutical market has almost come to a halt in recent years, which is mainly as a result of falling incomes of the local population, freezing of state budgets for public procurements and tightened governmental control over the prices for vital drugs in Russia, according to recent statements of some leading Russian drugmakers and officials of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 27 February 2019